Stephen A. Varvel

3.0k total citations
51 papers, 2.2k citations indexed

About

Stephen A. Varvel is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Surgery. According to data from OpenAlex, Stephen A. Varvel has authored 51 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 19 papers in Pharmacology and 15 papers in Surgery. Recurrent topics in Stephen A. Varvel's work include Cannabis and Cannabinoid Research (18 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Neuroscience and Neuropharmacology Research (14 papers). Stephen A. Varvel is often cited by papers focused on Cannabis and Cannabinoid Research (18 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Neuroscience and Neuropharmacology Research (14 papers). Stephen A. Varvel collaborates with scholars based in United States, United Kingdom and Austria. Stephen A. Varvel's co-authors include Aron H. Lichtman, Billy R. Martin, Joseph P. McConnell, Sotirios Tsimikas, Benjamin F. Cravatt, Laura E. Wise, James V. Pottala, Emmanuel A. Anum, William S. Harris and Rebecca Hamm and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Stephen A. Varvel

51 papers receiving 2.2k citations

Peers

Stephen A. Varvel
Susanna Tchilibon United States
W.‐S. Vanessa Ho United Kingdom
Susan M. Huang United States
Emma Leishman United States
Marnie Duncan United Kingdom
Colin Stott United Kingdom
László Offertáler United States
Eileen M. Briley United States
Susanna Tchilibon United States
Stephen A. Varvel
Citations per year, relative to Stephen A. Varvel Stephen A. Varvel (= 1×) peers Susanna Tchilibon

Countries citing papers authored by Stephen A. Varvel

Since Specialization
Citations

This map shows the geographic impact of Stephen A. Varvel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen A. Varvel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen A. Varvel more than expected).

Fields of papers citing papers by Stephen A. Varvel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen A. Varvel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen A. Varvel. The network helps show where Stephen A. Varvel may publish in the future.

Co-authorship network of co-authors of Stephen A. Varvel

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen A. Varvel. A scholar is included among the top collaborators of Stephen A. Varvel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen A. Varvel. Stephen A. Varvel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Willeit, Peter, Calvin Yeang, Patrick M. Moriarty, et al.. (2020). Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events. Journal of the American Heart Association. 9(23). e016318–e016318. 38 indexed citations
2.
Moriarty, Patrick M., Calvin Yeang, Stephen A. Varvel, Joseph P. McConnell, & Sotirios Tsimikas. (2018). REMOVING THE LIPOPROTEIN(A)-CHOLESTEROL FROM THE LDL-C MEASUREMENT RESULTS IN A 38% REDUCTION IN PREVALENCE OF ELEVATED LDL-C AT ANY THRESHOLD: IMPLICATIONS FOR THE PREVALENCE AND DIAGNOSIS OF LDL-MEDIATED RISK. Journal of the American College of Cardiology. 71(11). A1783–A1783. 2 indexed citations
3.
Thompson, Steven, Stephen A. Varvel, Maciek Sasinowski, & J. P. Burke. (2016). From Value Assessment to Value Cocreation: Informing Clinical Decision-Making with Medical Claims Data. Big Data. 4(3). 141–147. 7 indexed citations
4.
Dayspring, Thomas, et al.. (2015). Biomarkers of cholesterol homeostasis in a clinical laboratory database sample comprising 667,718 patients. Journal of clinical lipidology. 9(6). 807–816. 28 indexed citations
5.
Varvel, Stephen A., Szilárd Vörös, Dawn L. Thiselton, et al.. (2014). Comprehensive Biomarker Testing of Glycemia, Insulin Resistance, and Beta Cell Function Has Greater Sensitivity to Detect Diabetes Risk Than Fasting Glucose and HbA1c and Is Associated with Improved Glycemic Control in Clinical Practice. Journal of Cardiovascular Translational Research. 7(6). 597–606. 13 indexed citations
6.
Harris, William S., James V. Pottala, Dawn L. Thiselton, et al.. (2014). Does APOE Genotype Modify the Relations Between Serum Lipid and Erythrocyte Omega-3 Fatty Acid Levels?. Journal of Cardiovascular Translational Research. 7(5). 526–32. 7 indexed citations
7.
Thompson, Steven, Stephen A. Varvel, Szilárd Vörös, et al.. (2013). The Changing Role of Ancillary Health Care Service Providers: An Evaluation of Health Diagnostic Laboratory, Inc.. Population Health Management. 17(2). 121–126. 2 indexed citations
8.
Wise, Laura E., Stephen A. Varvel, Dana E. Selley, et al.. (2011). ∆9-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory. Psychopharmacology. 217(4). 485–494. 15 indexed citations
9.
Varvel, Stephen A., Laura E. Wise, & Aron H. Lichtman. (2009). Are CB1 receptor antagonists nootropic or cognitive impairing agents?. Drug Development Research. 70(8). 555–565. 13 indexed citations
11.
Varvel, Stephen A., Billy R. Martin, & Aron H. Lichtman. (2007). Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to methamphetamine. Psychopharmacology. 193(4). 511–519. 15 indexed citations
12.
Pertwee, Roger G., Adèle Thomas, Ruth A. Ross, et al.. (2007). The psychoactive plant cannabinoid, Δ9‐tetrahydrocannabinol, is antagonized by Δ8‐ and Δ9‐tetrahydrocannabivarin in micein vivo. British Journal of Pharmacology. 150(5). 586–594. 77 indexed citations
13.
Varvel, Stephen A., et al.. (2006). Fatty Acid Amide Hydrolase (–/–) Mice Exhibit an Increased Sensitivity to the Disruptive Effects of Anandamide or Oleamide in a Working Memory Water Maze Task. Journal of Pharmacology and Experimental Therapeutics. 317(1). 251–257. 38 indexed citations
14.
Varvel, Stephen A., et al.. (2005). Δ9-Tetrahydrocannbinol Accounts for the Antinociceptive, Hypothermic, and Cataleptic Effects of Marijuana in Mice. Journal of Pharmacology and Experimental Therapeutics. 314(1). 329–337. 103 indexed citations
15.
Porter, Joseph H., Adam J. Prus, Robert E. Vann, & Stephen A. Varvel. (2004). Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats. Psychopharmacology. 178(1). 67–77. 20 indexed citations
16.
Varvel, Stephen A., et al.. (2002). Effects of antipsychotic drugs on operant responding after acute and repeated administration. Psychopharmacology. 160(2). 182–191. 30 indexed citations
17.
Varvel, Stephen A. & Aron H. Lichtman. (2002). Evaluation of CB1 Receptor Knockout Mice in the Morris Water Maze. Journal of Pharmacology and Experimental Therapeutics. 301(3). 915–924. 197 indexed citations
18.
Varvel, Stephen A., Rebecca Hamm, Billy R. Martin, & Aron H. Lichtman. (2001). Differential effects of Δ 9 -THC on spatial reference and working memory in mice. Psychopharmacology. 157(2). 142–150. 133 indexed citations
19.
Porter, Joseph H., et al.. (2000). Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats. Psychopharmacology. 149(2). 189–193. 29 indexed citations
20.
Wiley, Jenny L., et al.. (1998). Effects of modulation of NMDA neurotransmission on response rate and duration in a conflict procedure in rats. Neuropharmacology. 37(12). 1527–1534. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026